Cogentix Medical, Inc.
CGNT
CGNT was delisted on the 20th of April, 2018.
0 hedge funds and large institutions have $0 invested in Cogentix Medical, Inc. in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 47 closing their positions.
100% less funds holding
Funds holding: 47 → 0 (-47)
100% less capital invested
Capital invested by funds: $39.1M → $0 (-$39.1M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 47
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$14M |
| 2 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$4.07M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.97M |
| 4 |
Renaissance Technologies
New York
|
-$3.87M |
| 5 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$1.86M |
CGNT Hedge Fund Activity: Q2 2018 in Review
0 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q2 2018, worth a combined $0 — down 100% from $39.1M a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of CGNT and 0 opened new positions — a net loss of 47 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Nantahala Capital Management, exiting entirely with an estimated $14M sold.
- 0 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q2 2018, down from 47 in Q1 2018.
- Funds reported $0 of Cogentix Medical, Inc. stock for Q2 2018, down 100% quarter-over-quarter.
- 0 funds opened new Cogentix Medical, Inc. positions in Q2 2018 and 47 closed out, a net change of -47 holders.
- The largest Cogentix Medical, Inc. seller in Q2 2018 was Nantahala Capital Management, an estimated $14M sold.
Based on aggregated 13F filings for Q2 2018.